Cargando…

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer

SIMPLE SUMMARY: TNBC is the most aggressive type of breast cancer affecting women worldwide, and chemoresistance poses a significant clinical challenge associated with a poor prognosis. The molecular mechanisms causing this treatment resistance in TNBC patients have not been extensively studied. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adinew, Getinet M., Messeha, Samia, Taka, Equar, Soliman, Karam F. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659000/ https://www.ncbi.nlm.nih.gov/pubmed/36358602 http://dx.doi.org/10.3390/cancers14215180

Ejemplares similares

The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2021)

Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells
por: Adinew, Getinet M., et al.
Publicado: (2022)

Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells
por: Adinew, Getinet M., et al.
Publicado: (2023)

Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells
por: Adinew, Getinet M., et al.
Publicado: (2022)

Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment
por: Adinew, Getinet M., et al.
Publicado: (2021)

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
por: Payne, Ashley, et al.
Publicado: (2022)

Molecular Mechanisms of the Anti-Inflammatory Effects of Epigallocatechin 3-Gallate (EGCG) in LPS-Activated BV-2 Microglia Cells
por: Payne, Ashley, et al.
Publicado: (2023)

Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020)

Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells
por: Ahmed, Shade’ A., et al.
Publicado: (2023)

Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells
por: Messeha, Samia S., et al.
Publicado: (2020)

Molecular mechanism of gossypol mediating CCL2 and IL-8 attenuation in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020)

Pentagalloyl glucose inhibits TNF‐α‐activated CXCL1/GRO-α expression and induces apoptosis‐related genes in triple-negative breast cancer cells
por: Mendonca, Patricia, et al.
Publicado: (2021)

Effects of gossypol on apoptosis-related gene expression in racially distinct triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2019)

The inhibitory effects of butein on cell proliferation and TNF-α-induced CCL2 release in racially different triple negative breast cancer cells
por: Mendonca, Patricia, et al.
Publicado: (2019)

Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells
por: Messeha, Samia S., et al.
Publicado: (2022)

The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2018)

The BIRC Family Genes Expression in Patients with Triple Negative Breast Cancer
por: Makuch-Kocka, Anna, et al.
Publicado: (2021)

Proteomic analysis of the effect of the polyphenol pentagalloyl glucose on proteins involved in neurodegenerative diseases in activated BV-2 microglial cells
por: Mendonca, Patricia, et al.
Publicado: (2019)

Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer
por: Messeha, Samia S., et al.
Publicado: (2021)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer
por: Li, Yongpeng, et al.
Publicado: (2021)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021)

Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
por: Wang, Chen, et al.
Publicado: (2012)

Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
por: Dai, Jian-bo, et al.
Publicado: (2020)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
por: He, Lin, et al.
Publicado: (2021)

The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5
por: Yu, Xiaojie, et al.
Publicado: (2019)

Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications
por: Liu, Shenting, et al.
Publicado: (2023)

Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor
por: Zarmouh, Najla O., et al.
Publicado: (2016)

Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors
por: Zarmouh, Najla O., et al.
Publicado: (2016)

Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
por: Oparina, Nina, et al.
Publicado: (2021)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
por: Luo, Hong, et al.
Publicado: (2021)

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
por: Chakrabarty, Anindita, et al.
Publicado: (2021)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer
por: Shi, Bingye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sav5efc7rfl69ee160kjeie9p8